NOVONIX Ltd Files Form 6-K with Appendix 3H
Ticker: NVNXF · Form: 6-K · Filed: Dec 10, 2024 · CIK: 1859795
Sentiment: neutral
Topics: filing, disclosure, foreign-private-issuer
TL;DR
NOVONIX dropped a 6-K update with Appendix 3H on Dec 10th. Stay tuned.
AI Summary
NOVONIX Limited filed a Form 6-K on December 10, 2024, reporting information for the month of December 2024. The filing includes Appendix 3H, which is a notification regarding the company's activities. NOVONIX is incorporated in Australia and its principal executive office is located in Brisbane.
Why It Matters
This filing provides an update on the company's activities and disclosures, which is important for investors to stay informed about the latest developments at NOVONIX.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily serves as a notification and does not appear to contain significant new financial or operational disclosures.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- December 10, 2024 (date) — Filing Date
- Appendix 3H (document) — Included Exhibit
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the company has made or is required to make public pursuant to the laws of its home country, or that it has filed or is required to file with a stock exchange on which its securities are traded.
What is Appendix 3H mentioned in the filing?
Appendix 3H is listed as an exhibit in the Form 6-K, indicating it is a notification or disclosure document being provided by NOVONIX Limited.
Where is NOVONIX Limited's principal executive office located?
NOVONIX Limited's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
What is the SEC file number for NOVONIX Limited?
The SEC file number for NOVONIX Limited is 001-41208.
Does NOVONIX Limited file annual reports under Form 20-F or 40-F?
NOVONIX Limited indicates it files annual reports under cover of Form 20-F.
Filing Stats: 210 words · 1 min read · ~1 pages · Grade level 13.1 · Accepted 2024-12-10 16:30:03
Filing Documents
- nvx-6k-dec-24-12-10_app3.htm (6-K) — 19KB
- nvx-ex99_1.htm (EX-99.1) — 65KB
- nvx-ex99_2.htm (EX-99.2) — 66KB
- img58969013_0.jpg (GRAPHIC) — 1KB
- img59892534_0.jpg (GRAPHIC) — 1KB
- 0000950170-24-134996.txt ( ) — 154KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: December 10, 2024